Showing results (141-150 of 155) with videos related to
Sort By:
Pageof 16
Bulletin of the World Health Organization|December 2, 2025
Target product profiles for paediatric formulations of azithromycin and nitrofurantoinYasir Bin Nisar, Giulia Brigadoi, Shabina Ariff, et al.The Lancet. HIV|April 15, 2018
Effect of ready-to-use supplementary food on mortality in severely immunocompromised HIV-infected individuals in Africa initiating antiretroviral therapy (REALITY): an open-label, parallel-group, randomised controlled trialJane Mallewa, Alexander J Szubert, Peter Mugyenyi, et al.The Lancet. HIV|August 14, 2025
Research gaps for children who are HIV-exposed but uninfected: outcomes of a research prioritisation workshopCatherine J Wedderburn, Ceri Evans, Elaine J Abrams, et al.Plos One|April 24, 2018
Weekends-off efavirenz-based antiretroviral therapy in HIV-infected children, adolescents and young adults (BREATHER): Extended follow-up results of a randomised, open-label, non-inferiority trialAnna Turkova, Cecilia L Moore, Karina Butler, et al.Medrxiv : the Preprint Server for Health Sciences|November 24, 2025
PERFORMANCE OF FUJILAM VERSION 1 FOR THE DIAGNOSIS OF TUBERCULOSIS IN CHILDREN UNDER 5 YEARS IN UGANDA - A BRIEF REPORTMirembe Angella Nanteza, Nelson Mukiza, Freddie Bwanga, et al.BMC Infectious Diseases|January 15, 2021
ODYSSEY clinical trial design: a randomised global study to evaluate the efficacy and safety of dolutegravir-based antiretroviral therapy in HIV-positive children, with nested pharmacokinetic sub-studies to evaluate pragmatic WHO-weight-band based dolutegravir dosingCecilia L Moore, Anna Turkova, Hilda Mujuru, et al.Lancet (London, England)|July 23, 2026
Oral step-down, optimal drug, and total duration of antibiotic treatment in African children hospitalised with severe community-acquired pneumonia (PediCAP): a factorial randomised controlled trialJulia A Bielicki, Michelle Clements, Victor Musiime, et al.Science Translational Medicine|April 5, 2019
Cotrimoxazole reduces systemic inflammation in HIV infection by altering the gut microbiome and immune activationClaire D Bourke, Ethan K Gough, Godfrey Pimundu, et al.Journal of the Pediatric Infectious Diseases Society|October 16, 2023
First-Line Antituberculosis Drug Concentrations in Infants With HIV and a History of Recent Admission With Severe PneumoniaChishala Chabala, Tom G Jacobs, Cinta Moraleda, et al.Journal of the International AIDS Society|September 28, 2023
Effect of dolutegravir on folate, vitamin B12 and mean corpuscular volume levels among children and adolescents with HIV: a sub-study of the ODYSSEY randomized controlled trialLinda Namutebi Barlow-Mosha, Grace Miriam Ahimbisibwe, Elizabeth Chappell, et al.Pageof 16